Goodwin houses a ‘biotech specialised’ practice known for handling high-profile series financings, as well as research and collaboration agreements for biotech companies and investors. Dividing his time between London and Cambridge, Malcolm Bates stands out for his longstanding experience in commercial IP issues, with a strong focus on licensing and partnership transactions, jointly leading the team alongside David Mardle, who is noted for his vast knowledge of tech and life sciences financing transactions and M&A. Practice co-lead Tim Worden is a key name for R&D and clinical trial agreements, and the regulatory aspects of M&A. Georgia Powell is recommended for her broad experience spanning distribution and manufacturing transactions within the healthcare and tech sectors.

Jointly led by Ross McNaughton and Adrian Toutoungi in Cambridge, Taylor Wessing LLP’s practice is well-known for handling the full spectrum of mandates within the biotech industry, particularly relating to AI. McNaughton is a key contact for public capital raising, M&A, and venture financing mandates within the diagnostics, digital health, and medical device spaces. Toutoungi is recommended for his longstanding experience in assisting biologics, gene therapy, and small-molecule therapeutics clients with licensing and distribution issues. Dividing his time between Cambridge and London, Colin McCall is noted for his work concerning R&D projects and collaboration agreements. Key members of the team include Charlie Adams, who focuses on IP commercialisation within the life sciences space, and Oli Denne, who specialises in venture capital fundraising mandates.

The team at Mills & Reeve LLP is noted for its ‘expert background’ and ‘vast experience’ and often acts for a diverse range of pharma and diagnostic companies, research charities, and investors on fundraising matters. James Fry leads the team, and is noted for his deep knowledge of IP licensing and medicinal product promotional work. Promoted to partner in May 2024, Stephanie Caird draws on her prior in-house experience at major life sciences companies to advise on the regulatory aspects of clinical trials and research collaborations. Zickie Lim leads the firm’s venture capital and equity investments practice, utilising his longstanding experience to assist on major university spin outs.

Penningtons Manches Cooper LLP's ‘highly knowledgeable and professional’ team is well-equipped to assist clients with leases, as well as services and consultancy agreements. The group acts for a diverse client base of health tech companies, lab equipment suppliers, and medical research charities. Praised by clients for her ‘remarkable’ level of expertise, practice head Rachel Bradley is well-known for her specialism in manufacturing and material transfer issues, in addition to software and trademark licensing work within the biotech industry. Employment expert Hilary Aldred is well-equipped to assist with the full range of biotech-related work concerning reorganisations.